Geode Capital Management LLC grew its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 1.6% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,483,184 shares of the company’s stock after purchasing an additional 53,554 shares during the period. Geode Capital Management LLC’s holdings in DocuSign were worth $215,789,000 at the end of the most recent quarter.
Several other hedge funds also recently made changes to their positions in DOCU. Thrivent Financial for Lutherans bought a new stake in shares of DocuSign during the 2nd quarter valued at $115,795,000. Pacer Advisors Inc. raised its stake in DocuSign by 77.9% in the second quarter. Pacer Advisors Inc. now owns 3,519,969 shares of the company’s stock valued at $188,318,000 after purchasing an additional 1,541,816 shares in the last quarter. KBC Group NV lifted its position in DocuSign by 209.8% during the third quarter. KBC Group NV now owns 1,156,874 shares of the company’s stock worth $71,830,000 after purchasing an additional 783,419 shares during the period. Renaissance Technologies LLC grew its stake in DocuSign by 18.3% during the second quarter. Renaissance Technologies LLC now owns 3,729,314 shares of the company’s stock worth $199,518,000 after buying an additional 576,414 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ increased its holdings in DocuSign by 151.3% in the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 865,872 shares of the company’s stock valued at $46,324,000 after buying an additional 521,292 shares during the period. 77.64% of the stock is owned by institutional investors.
Insider Activity at DocuSign
In related news, CEO Allan C. Thygesen sold 7,648 shares of the business’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $62.47, for a total value of $477,770.56. Following the sale, the chief executive officer now owns 115,589 shares of the company’s stock, valued at $7,220,844.83. The trade was a 6.21 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Daniel D. Springer sold 581,588 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total value of $56,437,299.52. Following the completion of the sale, the director now owns 906,430 shares in the company, valued at $87,959,967.20. The trade was a 39.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 651,184 shares of company stock worth $60,878,829 in the last quarter. 1.66% of the stock is owned by insiders.
DocuSign Trading Down 0.0 %
Analysts Set New Price Targets
A number of analysts have recently weighed in on DOCU shares. Bank of America upped their price target on shares of DocuSign from $60.00 to $68.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. JPMorgan Chase & Co. lifted their price target on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research note on Tuesday, December 3rd. Jefferies Financial Group boosted their price target on DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. JMP Securities raised their price objective on DocuSign from $108.00 to $124.00 and gave the company a “market outperform” rating in a research note on Friday, December 6th. Finally, Wells Fargo & Company boosted their target price on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, DocuSign has an average rating of “Hold” and a consensus price target of $92.45.
Read Our Latest Stock Analysis on DOCU
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
- Five stocks we like better than DocuSign
- How to Invest in the Best Canadian Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Plot Fibonacci Price Inflection Levels
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.